Orbimed Advisors - RELAY THERAPEUTICS INC ownership

RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 115 filers reported holding RELAY THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 1.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of RELAY THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,221,534
-67.0%
501,966
+43.4%
0.09%
-30.8%
Q2 2021$12,807,000
+5.8%
350,0000.0%0.13%
+15.0%
Q1 2021$12,100,000
-16.8%
350,0000.0%0.11%
-11.0%
Q4 2020$14,546,000
-2.4%
350,0000.0%0.13%
-32.1%
Q3 2020$14,907,000350,0000.19%
Other shareholders
RELAY THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Casdin Capital, LLC 6,923,574$58,227,2576.44%
Finepoint Capital LP 870,870$7,324,0173.65%
Nextech Invest Ltd. 1,196,409$10,061,8003.05%
MPM BioImpact LLC 1,352,133$11,371,4393.04%
SB INVESTMENT ADVISERS (UK) LTD 27,904,963$234,680,7391.93%
EcoR1 Capital, LLC 4,163,824$35,017,7601.18%
Integral Health Asset Management, LLC 800,000$6,728,0000.93%
Alphabet Inc. 1,568,753$13,193,2120.85%
HARBOURVEST PARTNERS LLC 296,402$2,492,7410.85%
Boxer Capital, LLC 1,819,132$15,298,9000.81%
View complete list of RELAY THERAPEUTICS INC shareholders